Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MIRA Pharmaceuticals, Inc. - Common Stock
(NQ:
MIRA
)
1.620
-0.080 (-4.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MIRA Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
In today's session, these stocks are experiencing unusual volume.
October 17, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
October 16, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data
October 16, 2025
MIRA Pharmaceuticals shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 16, 2025
Via
Benzinga
Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making
October 16, 2025
Via
Stocktwits
Dow Dips Over 100 Points; US Crude Oil Inventories Surge
October 16, 2025
Via
Benzinga
Topics
Stocks
Top movers analysis in the middle of the day on 2025-10-16: top gainers and losers in today's session.
October 16, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Thursday's session: gap up and gap down stocks
October 16, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
October 16, 2025
Via
Benzinga
Topics
Stocks
Stay updated with the stocks that are on the move in today's pre-market session.
October 16, 2025
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 16, 2025
Via
Benzinga
Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
October 16, 2025
Via
Benzinga
Why Mira Pharmaceuticals Shares Rose 69% After Hours?
October 16, 2025
Mira Pharmaceuticals shares surged 68.94% in after-hours trading after the company reported promising preclinical results for its pain treatment candidate, Mira-55.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 15, 2025
Via
Benzinga
Wednesday's after hours session: top gainers and losers
October 15, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Monday's after hours session: top gainers and losers
September 15, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
September 12, 2025
Via
Benzinga
Unusual volume stocks in Monday's session
July 07, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Which stocks have an unusual volume on Thursday?
July 03, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 03, 2025
Via
Benzinga
US Stocks Likely To Open Higher As Trump Announces Vietnam Trade Deal: S&P 500's Golden Cross 'Reason To Expect Better Than Average Returns,' Says Expert
July 03, 2025
U.S. stock futures were slightly higher on Thursday after a mixed close on Wednesday. Futures of major benchmark indices were trading higher.
Via
Benzinga
Topics
Government
Stocks
Why Datadog Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
July 03, 2025
Via
Benzinga
MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours
July 03, 2025
MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future...
Via
Benzinga
Topics
Cannabis
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 02, 2025
Via
Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
July 02, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
EXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study
June 30, 2025
MIRA's to be acquired SKNY-1 cut weight and food cravings in animals, reversed liver fat, and reduced nicotine desire—without triggering muscle loss or overstimulation.
Via
Benzinga
MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong
May 09, 2025
Retail sentiment on Stocktwits surged, with users expressing optimism about the merger’s success, despite a pullback in after-hours trading.
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 08, 2025
Via
Benzinga
EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million
May 08, 2025
Mira Pharmaceuticals to acquire SKNY in a stock-based deal valuing both firms near $30 million each, backed by third-party pipeline valuation reports.
Via
Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
May 06, 2025
Ketamir-2 from MIRA Pharmaceuticals showed no brain toxicity in rats, meeting FDA study requirements and advancing its clinical development program.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.